Non-hdl-c
Searched over 200M research papers for "non-hdl-c"
Summary
10 papers analyzed
These studies suggest that non-HDL-C is a significant predictor of cardiovascular risk, coronary heart disease, and mortality, and is more strongly associated with atherosclerosis and other risk factors than LDL-C.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
The Role of Non-HDL Cholesterol in Cardiovascular Disease
Introduction to Non-HDL Cholesterol
Non-high-density lipoprotein cholesterol (non-HDL-C) has emerged as a significant marker in the assessment of cardiovascular disease (CVD) risk. Unlike low-density lipoprotein cholesterol (LDL-C), non-HDL-C encompasses all atherogenic lipoproteins, including very-low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL), making it a comprehensive measure of cholesterol that can contribute to atherosclerosis.
Non-HDL-C vs. LDL-C in Predicting Cardiovascular Risk
Several studies have demonstrated that non-HDL-C is a more potent predictor of cardiovascular events compared to LDL-C. A meta-analysis involving 233,455 subjects found that non-HDL-C had a stronger relative risk ratio (RRR) for cardiovascular events than LDL-C, with non-HDL-C being intermediate between LDL-C and apolipoprotein B (apoB) in terms of predictive power. Another study confirmed that non-HDL-C was more closely associated with atherogenic lipoprotein subfractions than LDL-C in patients with stable coronary artery disease (CAD).
Non-HDL-C and Coronary Heart Disease (CHD)
Non-HDL-C has been shown to be a significant predictor of coronary heart disease (CHD) in both the general population and specific patient groups. A meta-analysis of prospective observational studies revealed that individuals with the highest baseline non-HDL-C levels had a significantly greater risk of CHD compared to those with the lowest levels, with the risk being more pronounced in men. Additionally, elevated non-HDL-C levels were associated with increased mortality in patients with existing CHD, highlighting its prognostic value.
Non-HDL-C and Subclinical Atherosclerosis
Non-HDL-C is also strongly associated with subclinical markers of atherosclerosis, such as coronary artery calcification (CAC). Studies have shown that non-HDL-C levels measured at various life stages, including adolescence, young adulthood, and mid-adulthood, are linked to the presence of CAC in mid-adulthood, with the strongest association observed during adolescence. Furthermore, non-HDL-C was found to be more strongly associated with subclinical atherosclerosis than other conventional lipid measures, suggesting its importance in early detection and prevention strategies.
Non-HDL-C and Other Health Conditions
Beyond cardiovascular disease, non-HDL-C has been linked to other health conditions. For instance, a cross-sectional analysis of NHANES data indicated a positive association between non-HDL-C levels and depression, particularly in men and individuals without hypertension. This suggests that non-HDL-C may have broader implications for overall health beyond its role in cardiovascular risk.
Conclusion
Non-HDL cholesterol is a critical marker for assessing cardiovascular risk, offering advantages over traditional measures like LDL-C. Its strong association with both clinical and subclinical markers of atherosclerosis, as well as its predictive value for mortality in CHD patients, underscores its importance in both primary and secondary prevention of cardiovascular disease. Future research should continue to explore the broader health implications of non-HDL-C and refine its use in clinical practice.
Sources and full results
Most relevant research papers on this topic
